HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the

Sara R Nass1, Arianna R S Lark1, Yun K Hahn2

  • 1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Medical College of Virginia (MCV) Campus, Richmond, VA 23298-0613, USA.

Hormones and Behavior
|June 25, 2021
PubMed

Insights

HIV-1 Tat and morphine impair social behavior by disrupting oxytocin levels in brain circuits. This research highlights neurobiological links between HIV-1 infection, opioid use, and social deficits.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Individuals with HIV-1 infection and opioid dependence often exhibit social interaction deficits.
  • Sociability is regulated by the prefrontal cortico-hippocampal-amygdalar circuit, which is affected by HIV-1 trans-activator of transcription (Tat) and opioids.
  • Dysregulation of hypothalamic neuropeptides, including oxytocin and corticotropin-releasing factor (CRF), is linked to social behavior changes.

Purpose of the Study:

  • To investigate the combined effects of HIV-1 Tat and morphine on social interactions in male mice.
  • To examine the impact of HIV-1 Tat and morphine on oxytocin and CRF levels within the prefrontal cortex (PFC) and associated brain circuitry.
  • To determine the correlation between neuropeptide levels and behavioral alterations.

Main Methods:

  • Male mice were exposed to HIV-1 Tat for 8 weeks.
  • Morphine or saline was administered during the final 2 weeks of Tat exposure.
  • Social interactions were assessed using the resident-intruder test, social interaction test, and novelty test.
  • Oxytocin and CRF levels, as well as oxytocin-immunoreactive neurons, were measured in specific brain regions (PFC, amygdala, hypothalamic paraventricular nucleus).

Main Results:

  • HIV-1 Tat exposure alone attenuated aggressive social interactions.
  • Morphine administration decreased both aggressive and non-aggressive social interactions.
  • Tat, but not morphine, reduced oxytocin levels in the PFC and amygdala.
  • Both Tat and morphine decreased the percentage of oxytocin-immunoreactive neurons in the hypothalamic paraventricular nucleus (PVN).
  • Regional CRF and oxytocin levels correlated with behavioral changes in social interaction and novelty tests.

Conclusions:

  • Decreased oxytocin expression in the prefrontal cortico-hippocampal-amygdalar circuit is associated with social behavior deficits induced by morphine and HIV-1 Tat.
  • These findings elucidate the neurobiological mechanisms underlying social impairments in HIV-1 infected and opioid-dependent individuals.
  • Targeting oxytocin pathways may offer therapeutic potential for social deficits in these populations.

Related Concept Videos